SCHEMBL20129693

SCHEMBL20129693

COC(=O)c1cc(NC2CCN(c3ccccc3C#N)CC2)c(C)cc1F

nearest known ligand 0.61

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MTOR P42345 8/20 0.61
RPTOR Q8N122 8/20 0.61
MLST8 Q9BVC4 8/20 0.61
ALDH1A1 P00352 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
KMT2A Q03164 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
DPP4 P27487 1/20 0.42
ADRA1D P25100 2/20 0.42
ADRA1A P35348 2/20 0.42
ADRA1B P35368 2/20 0.42
KDM4E B2RXH2 2/20 0.40
LMNA P02545 1/20 0.40
BDKRB1 P46663 1/20 0.40
SMPD3 Q9NY59 1/20 0.40
GPR6 P46095 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20133701 0.93 MTOR (0.61) MTORRPTORMLST8ALDH1A1SMN1; SMN2
SCHEMBL20129666 0.91 MTOR (0.62) MTORRPTORMLST8ALDH1A1KMT2A
SCHEMBL20129691 0.90 MTOR (0.63) MTORRPTORMLST8ALDH1A1SMN1; SMN2
SCHEMBL20133548 0.87 MTOR (0.56) MTORRPTORMLST8ALDH1A1KMT2A
SCHEMBL20133693 0.85 MTOR (0.54) MTORRPTORMLST8ALDH1A1SMN1; SMN2
SCHEMBL20133856 0.85 MTOR (0.56) MTORRPTORMLST8ALDH1A1KMT2A
SCHEMBL20133700 0.85 MTOR (0.62) MTORRPTORMLST8ALDH1A1SMN1; SMN2
SCHEMBL20141296 0.85 MTOR (0.53) MTORRPTORMLST8ALDH1A1KMT2A
SCHEMBL20133723 0.84 MTOR (0.55) MTORRPTORMLST8BDKRB1
SCHEMBL20141071 0.83 MTOR (0.53) MTORRPTORMLST8ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10844013-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof NAVITOR PHARMACEUTICALS, INC. (US) 2020-11-24 US disclosed
US-20200207716-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. 2020-07-02 US disclosed
US-10414727-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof NAVITOR PHARMACEUTICALS, INC. (US) 2019-09-17 US disclosed
WO-2018089499-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed
US-20180127370-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. 2018-05-10 US disclosed
US-20180127370-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10844013-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof MTOR, RICTOR, RPTOR MTOR 1/4885RPTOR 3/4885MLST8 7/4885
US-10414727-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof MTOR, RICTOR, RPTOR MTOR 1/4885RPTOR 3/4885MLST8 7/4885
US-20180127370-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF MTOR, RICTOR, RPTOR MTOR 1/4885RPTOR 3/4885MLST8 7/4885
US-20200207716-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF MTOR, RICTOR, RPTOR MTOR 1/4885RPTOR 3/4885MLST8 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.